Physician profile
Carivette Lymari Toro
NPI 1659604775
$1,011.69
in general payments reported to CMS, 2019-2025
8 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Obesity Medicine (Preventive Medicine) provider received nationally (typical 2025 total: $203).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $269 · 2021: $120 · 2022: $61.88 · 2023: $50.00 · 2024: $164 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $616.81 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $118.71 | 2024 | Zepbound |
| Kvk-Tech, INC. | $103.23 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.93 | 2019-2024 | Jardiance, Synjardy |
| Janssen Pharmaceuticals, INC | $41.66 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $20.00 | 2024 | Fasenra |
| Sanofi-Aventis U.S. LLC | $20.00 | 2020 | |
| Galderma Laboratories, L.P. | $19.35 | 2025 | Dysport |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carivette Toro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.